Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$50,775,837
in 5 filings, $50.8M under 10b5-1 plans

Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-12 Bancel Stephane Chief Executive Officer Grant or award +13,233 5,500,297
2025-02-12 Bancel Stephane Chief Executive Officer Shares withheld for taxes −6,400 $30.93 $198K 5,493,897
2025-02-07 Hoge Stephen President Exercise or conversion 10b5-1 +523 1,444,427
2025-02-07 Hoge Stephen President Shares withheld for taxes 10b5-1 −281 $33.61 $9K 1,444,146
2025-02-07 Hoge Stephen President Exercise or conversion · Restricted Stock Units 10b5-1 −523 0
2025-01-03 Mock James M Chief Financial Officer Exercise or conversion 10b5-1 +1,453 12,519
2025-01-03 Mock James M Chief Financial Officer Shares withheld for taxes 10b5-1 −780 $42.00 $33K 11,739
2025-01-03 Mock James M Chief Financial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −1,453 10,169
2024-12-09 Klinger Shannon Thyme Chief Legal Officer Sale 10b5-1 −529 $44.68 $24K 20,446
2024-12-06 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion 10b5-1 +1,138 20,975
2024-12-06 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion · Restricted Stock Units 10b5-1 −1,138 2,278
2024-12-05 Mock James M Chief Financial Officer Grant or award · Restricted Stock Units +188,761 188,761
2024-12-05 Klinger Shannon Thyme Chief Legal Officer Grant or award · Restricted Stock Units +188,761 188,761
2024-12-03 Klinger Shannon Thyme Chief Legal Officer Sale 10b5-1 −112 $43.30 $5K 19,837
2024-12-03 Hoge Stephen President Sale 10b5-1 −314 $43.30 $14K 1,443,904
2024-12-02 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion 10b5-1 +232 19,949
2024-12-02 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion · Restricted Stock Units 10b5-1 −232 1,164
2024-12-02 Hoge Stephen President Exercise or conversion 10b5-1 +651 1,444,218
2024-12-02 Hoge Stephen President Exercise or conversion · Restricted Stock Units 10b5-1 −651 3,259
2024-11-29 Mock James M Chief Financial Officer Sale 10b5-1 −1,420 $42.79 $61K 11,066

Page 21 of 38 · 743 trades